DOI: 10.1055/s-00000030

Der Klinikarzt

References

Guarneri V, Bisagni G, Frassoldati A. et al.
De-escalated treatment with trastuzumab-pertuzumab-letrozole in patients with HR+/HER2+ operable breast cancer with Ki67 response after 2 weeks letrozole: Final results of the PerELISA neoadjuvant study.
J Clin Oncol. 2018
36. (suppl; abstr 507)

Download Bibliographical Data

Search in: